This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Pharmaceutical Clusters Have A Future

KALUGA, Russia, December 6, 2012 /PRNewswire/ --

On November 21 the town of Obninsk, near Moscow, hosted the 3rd innovation forum PHARMEVOLUTION: Localization of Pharmaceutical Production and Research in Russia - Practice, Trends and Prospects.

The forum brought together representatives from federal agencies, government-run development institutions, the leading world and Russian pharmaceutical companies, centers of innovation, territorial clusters and related associations and institutions of higher learning.

The future of the innovative pharmaceutical industry in Russia was discussed. Among other things the forum focused on the experience of forming territories of innovative development as the basis for systemic research into and production of advanced medications. The need was emphasized for expanding the potential of pharmaceutical clusters through cooperation with major international and Russian pharmaceutical companies, small innovative businesses and research centers. This combination of measures will help address the task of localizing pharmaceutical production in Russia more effectively.

At present the Kaluga pharmaceutical cluster manufactures over 50 medications. Investment in its development has exceeded six billion rubles. Deputy Governor Maxim Shereikin said in the course of the discussion drawing unique specialists into the industry and creating the necessary conditions for training skilled personnel in the region was the main strategic task.

On the sidelines of the forum the non-commercial partnership Kaluga Pharmaceutical Cluster signed a memorandum of cooperation with the innovative cluster Chemical Cluster Bavaria. The signatories believe this will help expand science and business ties between the affiliated businesses. Joint work will also speed up the commercialization of research into systemic pharmaceutical technologies, the use of nanotechnologies in the health service and the recycling and disposal of pharmaceutical production wastes.

Also, a memorandum of intent was signed with the OJSC Rostechnologies-Biotechprom to create in the Kaluga Region a major specialized logistic complex for the pharmaceutical industry. The Kaluga industrial cluster has plans for cooperation with the biotechnological incubator of the M.V. Lomonosov Moscow State University with a view to implementing a number of projects and cooperating in education programs for the pharmaceutical industry.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs